Omixon Raises Capital, Launches US Office

14/05/2014

Omixon has opened its first offices in Cambridge, MA to support the growing demand from customers for their HLA genotyping software, Omixon Target™ HLA Typing. The US office will be responsible for all in-market activities relating to sales, support and training for Omixon’s products with an additional focus on business...

Omixon Awarded 100k Genome Research Grant

09/05/2014

Winners from a £10 million competition to help businesses develop new technology to map and analyse genes have been announced on 2 May. Eight companies were successful and will share a total of £1.6 million. The winners will use this funding from phase 1 of the competition to demonstrate the...

Omixon at This Year’s Immuno B4B-Connection Conference!

06/05/2014

Agnes Pasztor, Omixon’s Customer Support Manager and our French distributor WiraTech Europe‘s CEO Sami Djoulah, attended this year’s Immuno B4B-Connection in Charleroi Biopark, Belgium. At least 120 people from different companies participated in the 2 day conference, consisting of various presentations and introductions to the many different companies and their field of interest. A...

The Omixon Academy Launches!

31/03/2014

It’s a huge pleasure to announce that the Omixon Academy finally launches! This project was initiated last year based on the amazing feedback we received over our educational blog entries and decided to dedicate a whole new website to that. The Omixon Academy includes sections such as Education for materials,...

Our Brand New Website Is Up!

31/03/2014

After months of hard work, the brand new Omixon.com website is up and running. New sections such as Oncology were introduced to make sure users find what they are looking for. We hope you will like that!